The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Receptors for Dopamine and Somatostatin: Formation of Hetero-Oligomers with Enhanced Functional Activity
Abstract
Somatostatin and dopamine are two major neurotransmitter systems that share a number of structural and functional characteristics. Somatostatin receptors and dopamine receptors are colocalized in neuronal subgroups, and somatostatin is involved in modulating dopamine-mediated control of motor activity. However, the molecular basis for such interaction between the two systems is unclear. Here, we show that dopamine receptor D2R and somatostatin receptor SSTR5 interact physically through hetero-oligomerization to create a novel receptor with enhanced functional activity. Our results provide evidence that receptors from different G protein (heterotrimeric guanine nucleotide binding protein)–coupled receptor families interact through oligomerization. Such direct intramembrane association defines a new level of molecular crosstalk between related G protein–coupled receptor subfamilies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Somatostatin and Its Receptor Family
Patel, Y. C. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0183 · Cited by 1,648
Self-citationG-protein-coupled receptor heterodimerization modulates receptor function
Jordan, B. A., & Devi, L. A. (1999) · Nature · doi:10.1038/21441 · Cited by 1,166
Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers
Rocheville, M., Lange, D. C., Kumar, U., Sasi, R., Patel, R. C., & Patel, Y. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7862 · Cited by 527
Self-citationD1 and D2 dopamine receptor mRNA in rat brain.
Weiner, D. M., Levey, A. I., Sunahara, R. K., Niznik, H. B., O'Dowd, B. F., Seeman, P., & Brann, M. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1859 · Cited by 491
Dimerization of the δ Opioid Receptor:
Cvejic, S., & Devi, L. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26959 · Cited by 484
Somatostatin in the central nervous system: Physiology and pathological modifications
Epelbaum, J. (1986) · Progress in Neurobiology · doi:10.1016/0301-0082(86)90012-2 · Cited by 466
Gadella, T. W., & Jovin, T. M. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.6.1543 · Cited by 438
GABAB receptors – the first 7TM heterodimers
Marshall, F. H., Jones, K. A., Kaupmann, K., & Bettler, B. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01383-8 · Cited by 345
Kumar, U., Sasi, R., Suresh, S., Patel, A., Thangaraju, M., Metrakos, P., Patel, S. C., & Patel, Y. C. (1999) · Diabetes · doi:10.2337/diabetes.48.1.77 · Cited by 284
Self-citationDopamine D2 Receptor Dimers and Receptor-Blocking Peptides
Ng, G. Y. K., O'Dowd, B. F., Lee, S. P., Chung, H. T., Brann, M. R., Seeman, P., & George, S. R. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1489 · Cited by 273
Somatostatin receptors: identification and characterization in rat brain membranes.
Srikant, C. B., & Patel, Y. C. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3930 · Cited by 246
Self-citationIdentification and Molecular Characterization of m3 Muscarinic Receptor Dimers
Zeng, F.-Y., & Wess, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19487 · Cited by 245
Structural and functional aspects of G protein-coupled receptor oligomerization
Hébert, T. E., & Bouvier, M. (1998) · Biochemistry and Cell Biology · doi:10.1139/bcb-76-1-1 · Cited by 223
Molecular pharmacology of somatostatin receptors
Hoyer, D., L�bbert, H., & Bruns, C. (1994) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00173012 · Cited by 210
Somatostatin and thyrotropin releasing hormone: Central effect on sleep and motor system
Havlicek, V., Rezek, M., & Friesen, H. G. (1976) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(76)90063-0 · Cited by 140
Dopamine D2 Receptors in Signal Transduction and Behavior
Picetti, R., Saiardi, A., Samad, T. A., Bozzi, Y., Baik, J., & Borrelli, E. (1997) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v11.i2-3.20 · Cited by 125
George, S. R., Lee, S. P., Varghese, G. K., Zeman, P. R., Seeman, P. M., Ng, G., & O’Dowd, B. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30244 · Cited by 122
General Aspects of the Biology and Function of Somatostatin
Patel, Y. (1992) · Basic and clinical aspects of neuroscience · doi:10.1007/978-3-642-76948-1_1 · Cited by 79
Self-citation
Cited by
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
Reubi, J. C. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0007 · Cited by 1,131
G Protein-Coupled Receptor Allosterism and Complexing
Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 931
Molecular Structure and Physiological Functions of GABABReceptors
Bettler, B., Kaupmann, K., Mosbacher, J., & Gassmann, M. (2004) · Physiological Reviews · doi:10.1152/physrev.00036.2003 · Cited by 924
Neve, K. A., Seamans, J. K., & Trantham‐Davidson, H. (2004) · Journal of Receptors and Signal Transduction · doi:10.1081/lrst-200029981 · Cited by 837
Advances in the Treatment of Prolactinomas
Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A. (2006) · Endocrine Reviews · doi:10.1210/er.2005-9998 · Cited by 824
Metadata
- Authors
- Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., & Patel, Y. C.
- Venue
- Science
- Published
- 2000-04-07
- Volume
- 288
- Issue
- 5463
- Pages
- 154-157
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1988395319
- Cited by
- 888
- References
- 19
- FWCI
- 24.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.